Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for August 2007
August 1, 2007
- Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology
- Sanofi-aventis First Half 2007: Solid Results in a Difficult Context;
- SurModics Acquires Brookwood Pharmaceuticals
- Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.
- Teva Reports Second Quarter 2007 Results
- Southern Research Institute Spinout, Brookwood Pharmaceuticals, Acquired by SurModics for $62 Million
- Cell Therapeutics, Inc. Completes Acquisition of SMi
- Allergan Reports Second Quarter Operating Results
- Court Takes Matter of Wyeth's Motion for Preliminary Injunction Under Advisement; Obtains Agreement from Teva and Sun to Delay Any Potential Launch of Generic Pantoprazole
- Beijing Med-Pharm Announces That Alliance BMP Limited Has Received MOFCOM Approval to Acquire Interest in Guangzhou Pharmaceutical Corporation
- Reorganisation of Astellas European Business Functions
- Publicis Groupe Launches SSF Group
August 2, 2007
- Genentech Announces Expiration of Hart-Scott-Rodino Waiting Period and Completes Acquisition of Tanox
- Anadys Pharmaceuticals Announces Strategic Restructuring and Reports Second Quarter 2007 Financial Results
- PharmaNet Development Group Agrees to Settle 2005 Securities Class Action
- New IMS Health Report Finds Generic Drugs Used More in Part D than Commercial Market
- Schering-Plough Announces Dissolution of Consent Decree
August 3, 2007
- BIO Applauds Court of Appeals Decision
- FDA, Defense Department Share Data to Enhance Medical Product Safety Reviews
- Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD)
- Novo Nordisk: Financial Statement for the Period 1 January 2007 to 30 June 2007
- A Voluntary Recall of a Specific Batch of “Vesanoid Capsule,” a Treatment for Acute Promyelocytic Leukemia
- Appeals Court Strikes Down D.C. Drug Price Control Law
- Novo Nordisk Increased First Half-Year Operating Profit by 14% and Raises the Expectation for 2007 Operating Profit Growth to Around 10%
- GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start.
- Healthcare Acquisition Corp. and PharmAthene Receive Stockholder Approval for Their Merger
August 6, 2007
- Melior Discovery Enters New Pharmaceutical Collaboration
- Santarus Reports Second Quarter 2007 Financial Results
- Abbott Chief Operating Officer Richard A. Gonzalez to Retire
- Novartis Concerned Indian Court Ruling Will Discourage Investments in Innovation Needed to Bring Better Medicines to Patients
- Buzz in Pharma Blogs This Week Includes Pfizer HIV Marketers Getting Fired, FDA’s Hearing on Avandia, and Blogger Peter Rost is Taking Over for Journalist Jim Edwards at Brandweek NRX
August 7, 2007
- King Pharmaceuticals Reports Second-Quarter 2007 Financial Results
- KineMed and Merck Enter Collaboration in Atherosclerosis
- Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
- Healthcare Acquisition Corp. and PharmAthene, Inc. File Certificate of Merger to Complete Acquisition; Confirmation to Be Sought from Delaware Court of Chancery Regarding Stockholder Vote
- Bayer Continues On a Path of Growth
- ADHD Appears to Be Associated with Depressed Dopamine Activity in the Brain
- Marketing Authorisation for the Antiretroviral Medicinal Product Viracept is Suspended
- Multicultural Marketing of Health and Wellness to Women. the Trend Report Examines Ethnic & Demographic Differences in Health-care-related Opinions and Behaviors
- Asia Pacific to Replace United States and Europe as Pharmaceutical Industry Powerhouse, Finds PricewaterhouseCoopers
- Court Denies Terminally Ill Access to Experimental Drugs
August 8, 2007
- Biovail Enters Into License and Development Agreement
- Biovail Reports Second-Quarter 2007 Financial Results
- AVI BioPharma Announces Refocused Clinical Development Strategy
- Neuromed Announces that Merck & Co., Inc. Discontinues Development of Pain Drug Candidate, Joint Research Program Continues
- Galapagos Announces Expanded Relationship with AstraZeneca
- Bend Research and Pfizer Offer Proprietary Technology to Help Solve Drug-Discovery Challenges
August 9, 2007
- Shareholders Approve Peptech-EvoGenix Merger
- Johnson & Johnson Statement on Civil Complaint Against The American National Red Cross and Commercial Licensees
- AVEO Announces Successful Completion of Discovery Agreement for Novel Cancer Drugs
- IBM Introduces "ePedigree" System to Combat Drug Counterfeiting and Help Clients Comply With Regulations
- WuXi PharmaTech (Cayman) Inc. Announces Pricing of Initial Public Offering on NYSE
- J&J Sues Red Cross Over Use of Red Cross Emblem
- FDA - MedWatch - Prilosec (omeprazole), Nexium (esomeprazole)- Early Communication About An Ongoing Safety Review
- Health Canada Reviewing New Safety Information on Cardiac Events in Patients Taking Losec (omeprazole) or Nexium (esomeprazole)
- ImClone Systems Appoints John H. Johnson Chief Executive Officer
August 10, 2007
- Bradley Pharmaceuticals Special Committee Receives Non-binding Preliminary Bids
- NICE Responds to Judicial Review Outcome
- Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
- This Week Pharmaceutical Blogs Discuss Departure of Managers from Pfizer’s HIV Division, Approval of Selzentry, and Johnson & Johnson Suing the Red Cross
- Schering-Plough Corporation Prices Public Offering of Common Shares and 6.00% Mandatory Convertible Preferred Stock
August 13, 2007
- Roche and Actavis Agree on Product Transactions
- TGA: Urgent Advice Regarding Management of Patients Taking Lumiracoxib (Prexige)
- Sanofi pasteur First Manufacturer to Ship Doses of Influenza Vaccine for the 2007-2008 Season
- Important Dear Healthcare Provider letter about pediatric dosing
August 15, 2007
- Split off of CombiMatrix Corporation Completed Today on August 15, 2007
- Noven Completes Acquisition of JDS Pharmaceuticals
- FDA Sends Warning Letter to Novartis Over Professional File Card
- Epix Pharmaceuticals Achieves Discovery Milestone in Collaboration with GlaxoSmithKline
August 16, 2007
- Amgen Restructures Due to Lower Aranesp Revenues While Continuing to Invest in Innovation and Future Growth
- Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
- Cell Therapeutics, Inc. (CTI) Enters Agreement to Acquire Lymphoma Drug Zevalin from Biogen Idec for Sales and Marketing in the United States
- EvoGenix to Commence Second Project with GlaxoSmithKline
- GlaxoSmithKline Signs Contract for Its Pandemic Flu Vaccine with UK Government
- Parion Sciences and Gilead Sciences Sign Agreement to Advance Drug Candidates for Pulmonary Disease
- Novartis Starts US Shipment of Fluvirin Allowing for Early Influenza Vaccination of Millions of Americans
- Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for Xiaflex
- NEJM Direct-to-Consumer Ad Study Shows Drug Industry Incapable of Self- Regulation, Says AHF
- New Clinical Trial Guidelines Reflect Northwick Park Lessons
- Shanghai Century Acquisition Corporation Files Preliminary Proxy Statement
- FDA Approves Updated Warfarin (Coumadin) Prescribing Information
- FDA Announces Baraclude (entecavir) is Not Recommended for HIV/HBV Co-infected patients who are not also receiving HAART due to the potential for the development of HIV resistance
- Spherix Shareholders Support Company's Focus on Naturlose, Biotechnology
August 17, 2007
- Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
- Layoffs at Amgen and Increase in DTC Advertising Are the Dominating Topics in Pharmaceutical Blogs This Week
- FDA Announces Use of Codeine Products by Some Breastfeeding Mothers May Lead to Life-Threatening Side Effects in Nursing Babies
August 20, 2007
- Alcon's Tender Offer Endorsed by WaveLight AG's Executive Committee and Supervisory Board
- Pharming Reports Positive Results in European Placebo-Controlled Trial of Rhucin in Hereditary Angioedema
- PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
- MarkMonitor Brandjacking Index Exposes Online Scams That Threaten Top Pharmaceutical Brands and Hurt Consumers
- The Medical House PLC: Disposal of Needle-Free Insulin Injector Business (the “Disposal”)
- Chi-Med Announces Drug Discovery and Development Agreement with Eli Lilly and Company
- Mackler, Fisher, and Alta Communications Acquire HMP Communications
- FDA Approves ImClone Systems' New State-of-the-Art Manufacturing Facility
- PCMA: Minnesota is First in the Nation to Require E-Prescribing
August 21, 2007
August 22, 2007
- United States District Court for the District of Arizona Grants Roche's Motion for Preliminary Injunction
- Pfizer Names Frank A. D'Amelio Chief Financial Officer
- Prexige 200mg and 400mg Tablets to Be Withdrawn in New Zealand
- Deltagen Reports 2007 Second Quarter Financial Results and Announces a Restructuring
- Roche Extends Tender Offer for Ventana
- Ventana Responds to Second Extension of Roche's Unsolicited Tender Offer
- NICE Appraisal of Rituximab and Adalimumab for the Treatment of Arthritis
- NICE Recommends Natalizumab for the Treatment of Multiple Sclerosis
August 23, 2007
- Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated by Regeneron and sanofi-aventis
- GlaxoSmithKline Accelerates Review of Exelixis' XL880
- Abigail Alliance Will Appeal D.C. Circuit Court Decision
- GPC Biotech Announces Restructuring
- Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
- Teijin and Chugai Enter an Agreement to Co-develop Ipsen's Anti-diabetic Medicine in Japan
- MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
- Gene Logic Establishes Agreement with Merck Serono to Discover New Development Paths for Multiple Clinical-Stage Drug Candidates
August 24, 2007
- Flemming Lindeløv is Leaving the Lundbeck Supervisory Board
- Study Finds Viagra Increases Release of Key Reproductive Hormone
August 27, 2007
- Gene Logic and Solvay Pharmaceuticals Enter Agreement to Discover New Development Paths for Multiple Clinical Drug Candidates
- Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
- New 200 mg Vial for Eloxatin (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
- Neurochem Announces Results from Tramiprosate (Alzhemed) North American Phase III Clinical Trial
- This Week, Pharma Bloggers Discuss Pfizer’s New CFO, FDA Studying Imagery in DTC ADS, Risperdal Approved for Children and Teens, and Renewal of Chip
August 28, 2007
- KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
- Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon Development
- Curis Updates Research on Hedgehog Agonist Protein Program for Cardiovascular Disease Indications
- Multicultural Marketing of Health and Wellness to Women. the Trend Report Examines Ethnic & Demographic Differences in Health-care-related Opinions and Behaviors
- Xoma Licenses Antibody Technology to Pfizer
- Practicing What They Preach: GSK Announces Employee Wellness Initiative
- Statin Treatment May Curb Alzheimer's Brain Changes
- Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
- Inflazyme Pharmaceuticals Does Not Exercise Option with Helicon Therapeutics to PDE4 Inhibitor, IPL455,903, in Learning and Memory Disorders
August 29, 2007
- Court Rules That Roche Infringes One of Amgen's Erythropoietin Patents
- PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
- MGI Pharma Signs Agreement for Rights to Novel Treatment for Thrombocytopenia
- Merck Serono to Reconsider Development of Matuzumab in Metastatic Colorectal Cancer Patients
- Immunicon Announces Laboratory Services and Assay Development Agreements with Merck Serono
- National Asthma Guidelines Updated
- IMS Health, Wolters Kluwer Health and Verispan Challenge State Laws Restricting Access to Critical Healthcare Information
August 30, 2007
- Lilly and Takeda to Terminate Joint Development/Co-Marketing Agreement on Ruboxistaurin mesylate, An Agent for the Treatment of Diabetes Microvascular Complications
- King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
- GSK Supports Emphasis on Asthma Control and Use of Quick Assessment Tools in New Asthma Treatment Guidelines
- Cardiome And Astellas Announce Regulatory Extension
- Paion's Partner Forest Terminates Co-Development on Desmoteplase
- Pfizer Proves It Can Do More with Lipitor - Protecting Vital Access to Patients at the Heart of Winning Managed Care Strategy
August 31, 2007
- Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business
- Boehringer Ingelheim Voluntarily Withdraws Its Clobutinol Containing Medications
- AstraZeneca and Abbott Announce Selection of Next-Generation Fenofibrate (ABT-335) and Crestor Fixed-Dose Combination
